The Nature of Schizophrenia: Signposts to Prevention

Australian and New Zealand Journal of Psychiatry

Volumn 34, Issue , 2000, Pages S14-S21

  Mcgorry, Patrick D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

detection; early intervention; schizophrenia

Indexed keywords

AUSTRALIA; HUMAN; PSYCHOLOGY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER;

AUSTRALIA; HUMANS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 0348008175     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/000486700217     Document Type: Article

References (41)

1. Murray CJL, Lopez AD, eds. The global burden of disease. Boston: Harvard University Press, 1996.
2. DeLisi LE. 100 years of dementia praecox. Schizophrenia Research 1997; 28: 95.
3. Andreasen NC. Understanding the causes of schizophrenia. New England Journal of Medicine 1999; 340: 645–647.
4. Jablensky A, McGrath J, Herrman H et al. People living with psychotic illness: an Australian study. An overview. Overview of the method and results of low prevalence (psychotic) disorders as part of the national survey of mental health and wellbeing. Canberra: Low Prevalence Disorders Study Group, Commonwealth Department of Health and Age Care, 1999.
5. Amin A, Singh SP, Brewin J, Jones P, Medley I, Harrison G. Diagnostic stability of first episode psychosis. British Journal of Psychiatry 1999; 175: 537–543.
6. Mrazek PJ, Haggarty RJ. Reducing risks for mental disorders: frontiers for preventive intervention research. Washington, DC: National Academy Press, 1994.
7. Kraemer HC, Kazein AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Archives of General Psychiatry 1997; 54: 337–343.
8. Häfner H, Löffler W, Maurer K, Hambrecht M, Ander Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica 1999; 100: 105–118.
9. Häfner SM, Nowotny B, Loffler W, Ander Heiden W, Maurer K. When and how does schizophrenia produce social deficits?. European Archives of Psychiatry and Clinical Neuroscience 1995; 246: 17–28.
10. Eaton WW, Harrison G. Prevention priorities. Current Opinion in Psychiatry 1996; 9:141–143.
11. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. British Medical Journal 1995; 310: 452–454.
12. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. American Journal of Psychiatry 1998; 155: 1661–1670.
13. Van Os J, Bijl R, Ravelli A. Can the boundaries of psychosis be defined?. Schizophrenia Research 2000; 41: 8.
14. Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta-analysis. British Journal of Psychiatry 1995; 167: 786–793.
15. Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance and risk of schizophrenia. Journal of Psychiatric Research 1987; 21: 413–421.
16. Susser E, Neugebauer R, Hoek HW et al. Schizophrenia after prenatal famine: Further evidence. Archives of General Psychiatry 1996; 53: 25–31.
17. Jones P, Rodgers B, Murray R, Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994; 344: 1398–1402.
18. Lane A, Kinsella A, Murphy P et al. The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychological Medicine 1997; 27: 1155–1164.
19. Isohanni I, Jaervelin MR, Jones P, Jolelainen J, Isohanni M. Can excellent school performance be a precursor of schizophrenia? A 28-year follow-up in the Northern Finland 1966 birth cohort. Acta Psychiatrica Scandinavica 1999; 11: 17–26.
20. Mortensen PB, Pedersen CB, Westergaard T et al. Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 1999; 340: 603–608.
21. Tienari P, Wynne LC, Moring J et al. The Finnish adoptive family study of schizophrenia: implications for family research. British Journal of Psychiatry 1994; 164: 20–26.
22. McGorry P, Curry C. Cannabis use as a risk factor for development of psychotic symptoms: a prospective study. Inaugural International Cannabis and Psychosis Conference, Melbourne, 16-17 February, 1999.
23. Phillips L, Yung A, Hearn N, McFarlane C, Hallgren M, McGorry P. Preventive mental health care: accessing the target population. Australian and New Zealand Journal of Psychiatry 1999; 33: 912–917.
24. Van Os J, Ravelli A, Nijl RV. Evidence for a psychosis continuum in the general population. Schizophrenia Research 1999; 36: 57.
25. McGorry P, McFarlane C, Patton G et al. The prevalence of prodromal symptoms of schizophrenia in adolescence: a preliminary survey. Acta Psychiatrica Scandinavica 1995; 92: 241–249.
26. Brewer W, Francey S, Yung A et al. Cognitive and olfactory deficit: course from high risk to first episode psychosis. Abstract presented at the 9th Biennial Winter Workshop on Schizophrenia, 7–13 February, Davos, Switzerland. Schizophrenia Research 1998; 29: 1–2.
27. McGorry PD, Phillips LJ, Yung AR et al. A randomised controlled trial of interventions in the pre-psychotic phase of psychotic disorders. Schizophrenia Research 2000; 41: 9.
28. Wyatt R. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 1991; 17: 325–351.
29. Verdoux H, Bergey C, Assens F et al. Prediction of duration of psychosis before first admission. European Psychiatry 1998; 13: 346–352.
30. Harrigan SM, McGorry, PD Krstev H. Does treatment delay in first-episode psychosis really matter?. Schizophrenia Research 2000; 41: 177.
31. Carbone S, Harrigan S, McGorry P, Curry C, Elkins K. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatrica Scandinavica 1999; 100: 96–104.
32. Johannessen JO, Larsen TK, McGlashan T, Vaglum P. Early intervention in psychosis: the TIPS project, a multi-centre study in Scandinavia. In: Martindale B, Bateman A, Crowe M, Margison F (eds). Psychosis: Psychological approaches and their effectiveness. Glasgow: Gaskell, 2000.
33. McGlashan T. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biological Psychiatry 1999; 46:899–907.
34. Helgason L. Twenty years follow-up of first psychiatric presentation for schizophrenia: what could have been prevented?. Acta Psychiatrica Scandinavica 1990; 81: 231–235.
35. McGlashan TH. Early detection and intervention in schizophrenia: editor's introduction. Schizophrenia Bulletin 1996; 22: 197–199.
36. Mihalopoulos C, McGorry P, Carter R. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica 1999; 100: 47–55.
37. Cohen P, Cohen J. The clinician's illusion. Archives of General Psychiatry 1984; 41: 1178–1182.
38. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. American Journal of Psychiatry 1994; 151: 1409–1416.
39. Andrews G. Efficacy, effectiveness and efficiency in mental health service delivery. Australian and New Zealand Journal of Psychiatry 1999; 33: 316–322.
40. Singh BS, McGorry PD. The Second National Mental Health Plan: an opportunity to take stock and move forward. Medical Journal of Australia 1998; 169: 435–437.
41. McGorry PD. The MHS Debate. Who should be treated? Burden versus health gain. Australasian Psychiatry 1997; 5: 275–276.